Vaccine-adverse event reporting system: An essential tool for monitoring vaccine safety

Journal of the American Pharmacists Association

Volumn 46, Issue 2, 2006, Pages 298-299

  Hayney, Mary S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

DATA BASE; DRUG INDUSTRY; DRUG INFORMATION; DRUG LEGISLATION; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEALTH PRACTITIONER; HUMAN; IMMUNIZATION; PATIENT MONITORING; PUBLICATION; QUALITY CONTROL; SHORT SURVEY; UNSPECIFIED SIDE EFFECT; ARTICLE; DRUG SURVEILLANCE PROGRAM; FACTUAL DATABASE; INFANT; ORGANIZATION AND MANAGEMENT; SAFETY; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CONSUMER PRODUCT SAFETY; DATABASES, FACTUAL; HUMANS; INFANT; UNITED STATES; VACCINES;

EID: 33645814821     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/154434506776180757     Document Type: Article

References (4)

1. VAERS Vaccine Adverse Event Reporting System Web page. VAERS: CDC/FDA publications: 1999-2005. Accessed at www.vaers.hhs.gov/bibliography.htm, February 1, 2006.
2. Iskander JK, Miller ER, Pless RP, Chen RT. Vaccine safety post-marketing surveillance: the Vaccine Adverse Event Reporting System. Rockville, Md.: Department of Health and Human Services. Accessed at http://www.vaers.hhs.gov/ pdf/vaers_ce_new.pdf, February 1, 2006.
3. Centers for Disease Control and Prevention. Suspension of rotavirus vaccine after reports of intussusception-United States, 1999. MMWR Morb Mortal Wkly Rep. 2004;52:786-9. Accessed at www.cdc.gov/mmwr/PDF/wk/mm5334.pdf, February 1, 2006.
4. Centers for Disease Control and Prevention. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. MMWR Morb Mortal Wkly Rep 2003;52:1-24.